viagra

Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What's ahead for the world's biggest drugmaker:

How to Protect Yourself From Counterfeit Drugs Online

Even if the fake drug you buy online doesn't kill or even hurt you, the transaction itself can reveal your financial and medical information to questionable (at best) characters. Protecting yourself starts with understanding the dangers. Plus: Here are some helpful tips.

Pfizer Earnings Rise 9%, Topping Estimates

Pfizer (PFE) reported Tuesday that its second-quarter profit increased 9%, handily beating analyst expectations, as it further cut costs and revenue jumped sharply due to its acquisition of Wyeth last October.

Pfizer's Pipeline Looks Primed to Deliver

The stock of the world's largest drugmaker has been a laggard lately. But that could be soon changing if analysts who are pointing to a solid lineup of new products are right. They think the giant can easily offset the patent loss for Lipitor.